Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
8AU
0.00%
0.0¢
8 AU LIMITED
Currently unlisted.
Proposed listing date: 3 DECEMBER 2021 #
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
8AU | IPO - 8 Au Limited - 3 December 2021 # | 08/12/21 | 48 | 37K | |||
|
See All Discussions